Abstract: A pharmaceutical composition comprising idazoxan or derivatives and their therapeutically acceptable salts, racemates, optically active isomers and polymorphs.
Type:
Grant
Filed:
April 15, 2008
Date of Patent:
July 2, 2013
Assignee:
Pierre Fabre Medicament
Inventors:
Joel Bougaret, Jean-Louis Avan, Roland Segonds